Macular Disease Foundation Australia logo

Advocating for AMD treatment: White paper

Advocating for improved treatment and outcomes for wet age-related macular degeneration

This white paper was published by the US Angiogenesis Foundation as the result of a summit, co-convened with Macular Disease Foundation Australia.

The white paper is a report of the Australian Wet Age-Related Macular Degeneration Coalition Expert Summit, held in Sydney in July 2012. The summit marked a significant step forward in the fight against this eye disease.

The report identified the barriers in Australia to receiving timely and optimal care for wet (neovascular) age-related macular degeneration. It also articulated the potentially catastrophic outcomes for patients, as result of those many barriers.